Endometrial carcinoma and paraneoplastic immune thrombocytopenia
نویسندگان
چکیده
منابع مشابه
Sunitinib Induced Immune Thrombocytopenia
Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...
متن کاملSunitinib Induced Immune Thrombocytopenia
Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...
متن کاملParaneoplastic pauci-immune glomerulonephritis in a patient with lung carcinoma.
Alta hospitalaria 04-02-15 1,5 53 6.000 Pred. 60 mg/24 h CFM 1 g/m2 mes 09-06-15 1,8 43 1.800 129 Prot++++ Hb+++ 80-100 h/cp Pred. 20 mg/24 h Rituximab sem.×4 Suspensión CFM 27-07-15 1,7 43 2.000 107 Prot++++ Hb + ++ 80-100 h/cp AZA 50 mg/24 h Pred. 15 mg/24 h × 2 s Post. 10 mg/24 h 21-08-15 1,8 43 1.000 148 Prot++ Hb+++ 100 h/cp AZA 100 mg/24 h Pred. 10 mg/24 h 09-10-15 1,7 43 1.169 122 Prot++...
متن کاملImmune thrombocytopenia as a paraneoplastic syndrome in patients with nasopharyngeal cancer.
BACKGROUND Nasopharyngeal cancer (NPC) presenting with thrombocytopenia is rare. This report details 2 cases of NPC with grade III thrombocytopenia as a paraneoplastic syndrome. METHODS We present 2 cases of NPC in whom grade III thrombocytopenia was diagnosed concurrently at presentation. One patient underwent definitive intensity-modulated radiation therapy (IMRT) in combination with concur...
متن کاملImmune thrombocytopenia.
Immune thrombocytopenia (ITP) comprises a heterogeneous group of disorders characterized by autoimmune-mediated platelet destruction and impairment of thrombopoiesis. ITP may occur in the absence of an evident predisposing etiology (primary ITP) or secondary to a growing list of associated conditions (secondary ITP), and must be differentiated from other causes of thrombocytopenia. This review ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Oncological Science
سال: 2016
ISSN: 2452-3364
DOI: 10.1016/j.jons.2016.04.006